Detection of tumor ALK status in neuroblastoma patients using peripheral blood

New protocols based on ALK-targeted therapy by crizotinib or other ALK-targeting molecules have opened for the treatment of patients with neuroblastoma (NB) if their tumors showed mutation and/or amplification of the ALK gene. However, tumor samples are not always available for analysis of ALK mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Combaret, Valérie, Iacono, Isabelle, Bellini, Angela, Bréjon, Stéphanie, Bernard, Virginie, Marabelle, Aurélien, Coze, Carole, Pierron, Gaelle, Lapouble, Eve, Schleiermacher, Gudrun, Blay, Jean Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402069/
https://www.ncbi.nlm.nih.gov/pubmed/25653133
http://dx.doi.org/10.1002/cam4.414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402069/
https://www.ncbi.nlm.nih.gov/pubmed/25653133
http://dx.doi.org/10.1002/cam4.414

Ejemplares similares